Inventor · disambiguated record
Quentin J. Mccubbin
Also filed as: MCCUBBIN QUENTIN J
11 granted patents·12 pending applications·60 citations·filing 2008–2023
90Inventor score
Top patents by PatentIndex Score
23 records- 0195US8859504B2Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2012·Granted Oct 14, 2014·29 cites·15 claims
- 0292US9175018B2Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2014·Granted Nov 3, 2015·12 cites·40 claims
- 0391US11485746B2Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2020·Granted Nov 1, 2022·2 cites·14 claims
- 0487US9175017B2Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2014·Granted Nov 3, 2015·5 cites·13 claims
- 0587US2023265111A1Boronate ester compounds and pharmaceutical compositions thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 0686US10604538B2Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2019·Granted Mar 31, 2020·2 cites·1 claims
- 0786US10526351B2Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2019·Granted Jan 7, 2020·2 cites·1 claims
- 0882US8653064B2Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-D][2]benzazepin-2-yl]amino}-2-methoxybenzoateARMITAGE Ian·Filed 2011·Granted Feb 18, 2014·3 cites·20 claims
- 0980US2022009948A1Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2021·Application pending·0 cites
- 1078US10745404B2Process for the synthesis of E1 activating enzyme inhibitorsMILLENNIUM PHARM INC·Filed 2017·Granted Aug 18, 2020·1 cites·7 claims
- 1178US2021198289A1Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2021·Application pending·0 cites
- 1276US2020392164A1Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2020·Application pending·0 cites
- 1375US9802938B2Sulfamoylating reagentsMILLENNIUM PHARM INC·Filed 2014·Granted Oct 31, 2017·2 cites·18 claims
- 1474US8933225B2Process for the synthesis of E1 activating enzyme inhibitorsARMITAGE Ian·Filed 2008·Granted Jan 13, 2015·2 cites·14 claims
- 1574US2020181176A1Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2020·Application pending·0 cites
- 1672US2019263839A1Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2019·Application pending·0 cites
- 1771US2019048028A1Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2018·Application pending·0 cites
- 1870US2009325903A1Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2009·Application pending·0 cites
- 1969US2018208609A1Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2018·Application pending·0 cites
- 2068US2018002350A1Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2017·Application pending·0 cites
- 2163US2014357622A1Crystalline forms of sodium 4--2-methoxybenzoateMILLENNIUM PHARM INC·Filed 2014·Application pending·0 cites
- 2262US2016031913A1Boronate ester compounds and pharmaceutical compositions thereofMILLENNIUM PHARM INC·Filed 2015·Application pending·0 cites
- 2358US10017513B2Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido [5,4-D][2]benzazepin-2-YL]amino}-2-methoxybenzoateMILLENNIUM PHARM INC·Filed 2016·Granted Jul 10, 2018·0 cites·26 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →